The "Europe Thyroid Cancer Market and Competitive Landscape 2018" report has been added to ResearchAndMarkets.com's offering.
Research Scope
- Thyroid Cancer pipeline: Find out the drugs in clinical trials for Thyroid Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
- Thyroid Cancer epidemiology: Find out the prevalence of Thyroid Cancer by countries Europe, Germany, France, Italy, Spain, UK; prevalence forecast to 2023
- Thyroid Cancer products: Identify key products marketed and prescribed for Thyroid Cancer by brand name, by molecule, by company, by branded generic, by countries Europe, Germany, France, Italy, Spain, UK
- Thyroid Cancer market size: Find out the market size for Thyroid Cancer drugs by countries Europe, Germany, France, Italy, Spain, UK; Find out how the market advanced from 2014
- Thyroid Cancer drug sales: Find out the sales of Thyroid Cancer drugs by countries Europe, Germany, France, Italy, Spain, UK
- Thyroid Cancer drugs sales forecast: Sales forecast for Thyroid Cancer drugs to 2023 by countries Europe, Germany, France, Italy, Spain, UK
- Thyroid Cancer market share analysis: Find out the market shares of Thyroid Cancer drugs and outlook by countries Europe, Germany, France, Italy, Spain, UK
Key Topics Covered
1. Thyroid Cancer: Disease Overview
2. Thyroid Cancer Pipeline Insights
3. Thyroid Cancer Epidemiology Analysis
4. Germany Thyroid Cancer Market Insights
5. France Thyroid Cancer Market Insights
6. Italy Thyroid Cancer Market Insights
7. Spain Thyroid Cancer Market Insights
8. UK Thyroid Cancer Market Insights
9. Europe Thyroid Cancer Market Insights
10. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/research/qb5x8x/europe_thyroid?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181211005391/en/
Contacts:
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Thyroid Cancer Drugs